ALX Oncology Ownership | Who Owns ALX Oncology?
ALX Oncology Ownership Summary
ALX Oncology is owned by 77.73% institutional investors, 0.89% insiders, and 21.37% retail investors. Tcg crossover management is the largest institutional shareholder, holding 24.25% of ALXO shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 6.21% of its assets in ALX Oncology shares.
ALXO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ALX Oncology | 77.73% | 0.89% | 21.37% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tcg crossover management | 13.01M | 24.25% | $26.09M |
| Ra capital management | 13.01M | 24.25% | $26.09M |
| Venbio partners | 12.88M | 24.01% | $25.83M |
| Redmile group | 7.96M | 14.84% | $15.97M |
| Blackstone | 5.83M | 10.86% | $11.71M |
| Driehaus capital management | 5.73M | 10.69% | $11.50M |
| Almitas capital | 3.17M | 5.91% | $6.36M |
| 5am venture management | 3.06M | 5.70% | $6.13M |
| Blackrock funding, inc. /de | 7.71M | 5.69% | $10.72M |
| Blackrock | 2.69M | 5.36% | $16.21M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Venbio partners | 12.88M | 9.21% | $25.83M |
| 5am venture management | 3.06M | 1.70% | $6.13M |
| Almitas capital | 3.17M | 1.44% | $6.36M |
| Silverarc capital management | 6.57M | 1.07% | $9.13M |
| Redmile group | 7.96M | 1.06% | $15.97M |
| Caxton | 20.95K | 1.05% | $29.11K |
| Tcg crossover management | 13.01M | 0.75% | $26.09M |
| Ra capital management | 13.01M | 0.28% | $26.09M |
| Orbimed advisors | 2.87M | 0.11% | $5.75M |
| Driehaus capital management | 5.73M | 0.08% | $11.50M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 13.01M | 0.28% | 13.01M |
| Tcg crossover management | 13.01M | 0.75% | 13.01M |
| Blackstone | 5.83M | 0.05% | 5.83M |
| Redmile group | 7.96M | 1.06% | 4.70M |
| Driehaus capital management | 5.73M | 0.08% | 4.31M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | - | - | -3.60M |
| Vivo capital | - | - | -3.18M |
| Tang capital management | - | - | -3.16M |
| Cormorant asset management, lp | - | - | -3.14M |
| Adage capital partners gp | - | - | -2.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 13.01M | 0.75% | 13.01M | $26.09M |
| Ra capital management | 13.01M | 0.28% | 13.01M | $26.09M |
| Blackstone | 5.83M | 0.05% | 5.83M | $11.71M |
| 5am venture management | 3.06M | 1.70% | 3.06M | $6.13M |
| Orbimed advisors | 2.87M | 0.11% | 2.87M | $5.75M |
Sold Out
| Holder | Change |
|---|---|
| Srs capital advisors | -2.00 |
| Allspring global investments | -2.00 |
| Creekmur asset management | -4.00 |
| Farther finance advisors | -4.00 |
| Gamma investing | -12.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 98 | 36.11% | 105,438,934 | 11.85% | 77 | 0.96% | 69 | 53.33% | 10 | - |
| Mar 31, 2026 | 34 | -45.16% | 9,343,336 | -68.01% | 17 | 0.59% | 15 | -37.50% | 9 | -43.75% |
| Dec 31, 2025 | 11 | -82.54% | 2,731,277 | -90.17% | 5 | 0.19% | 4 | -76.47% | 2 | -93.75% |
| Sep 30, 2025 | 18 | -71.43% | 2,395,272 | -91.76% | 4 | 0.15% | 4 | -80.00% | 8 | -75.00% |
| Jun 30, 2025 | 63 | -26.74% | 29,075,912 | -13.08% | 54 | 1.38% | 20 | -39.39% | 32 | 10.34% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| HBM Healthcare Investments AG Ord | 8.59M | 6.21% | -5.45K |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.64M | 2.71% | - |
| Vanguard Total Stock Mkt Idx Inv | 3.64M | 2.71% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.64M | 2.63% | - |
| Vanguard US Total Market Shares ETF | 984.59K | 1.84% | - |
| iShares Russell 2000 ETF | 2.54M | 1.84% | - |
| Fidelity Select Biotechnology | 835.50K | 1.58% | - |
| Fidelity Stock Selector Small Cap | 837.11K | 1.57% | 10.71K |
| Fidelity Series Small Cap Opps | 769.53K | 1.44% | - |
| Fidelity Small Cap Value Fund | 678.40K | 1.29% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | $4.30K |
| Aug 17, 2026 | Wong Shelly | SVP, FINANCE AND CAO | Sell | $1.11K |
| Jul 01, 2026 | Wong Shelly | SVP, FINANCE AND CAO | Sell | $2.86K |
| Mar 19, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | $26.71K |
| Mar 19, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | $1.96K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 3 |
| 2026 Q2 | - | - |
| 2026 Q1 | 1 | 4 |
| 2025 Q4 | - | - |
| 2025 Q3 | 3 | 3 |
ALXO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools